Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Actinium Pharmaceuticals, Inc. (ATNM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/19/2022 |
4
| SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 07/01/2022 |
4
| O'Loughlin Steve (CFO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 256,438 options to buy
@ $0 |
|
| 07/01/2022 |
4
| Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 72,156 options to buy
@ $0 |
|
| 07/01/2022 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 72,156 options to buy
@ $0 |
|
| 07/01/2022 |
4
| Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 72,156 options to buy
@ $0 |
|
| 07/01/2022 |
4
| SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 827,366 options to buy
@ $0 |
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Chell Jeffrey W. (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 18,351 options to buy
@ $0 |
|
| 09/03/2021 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 67,164 options to buy
@ $0 |
|
| 09/03/2021 |
4
| Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 18,351 options to buy
@ $0 |
|
| 09/03/2021 |
4
| O'Loughlin Steve (CFO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 107,463 options to buy
@ $0 |
|
| 09/03/2021 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 18,351 options to buy
@ $0 |
|
| 09/03/2021 |
4
| SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 310,182 options to buy
@ $0 |
|
| 09/03/2021 |
4
| Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 18,351 options to buy
@ $0 |
|
| 08/14/2020 |
4
| O'Loughlin Steve (CFO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 59,066 options to buy
@ $0 |
|
| 08/14/2020 |
4
| SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 139,062 options to buy
@ $0 |
|
| 08/14/2020 |
4
| Chell Jeffrey W. (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 8,333 options to buy
@ $0 |
|
| 08/14/2020 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 46,667 options to buy
@ $0 |
|
| 08/14/2020 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 8,333 options to buy
@ $0 |
|
| 08/14/2020 |
4
| Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 8,333 options to buy
@ $0 |
|
| 08/14/2020 |
4
| Ludwig Dale L. (Chief Science & Tech. Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 08/14/2020 |
4
| Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 8,333 options to buy
@ $0 |
|
| 07/16/2019 |
4
| Steinhart Richard I (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.232, valued at
$58k
|
|
| 07/16/2019 |
4
| Chell Jeffrey W. (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.232, valued at
$58k
|
|
| 07/16/2019 |
4
| Ludwig Dale L. (Chief Scientific Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.232, valued at
$92.8k
|
|
| 07/16/2019 |
4
| O'Loughlin Steve (Principal Financial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.232, valued at
$92.8k
|
|
| 07/16/2019 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.232, valued at
$92.8k
|
|
| 07/16/2019 |
4
| SETH SANDESH (CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 1,500,000 options to buy
@ $0.232, valued at
$348k
|
|
| 07/16/2019 |
4
| Kapur Anil (Chief Commercial Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.232, valued at
$92.8k
|
|
| 07/16/2019 |
4
| Shetty Ajit (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.232, valued at
$58k
|
|
| 07/16/2019 |
4
| Nicholson, C. David (Director) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.232, valued at
$58k
|
|
| 03/07/2019 |
4
| Berger Mark Stanley (Chief Medical Officer) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,500 shares
@ $0.6, valued at
$2.1k
|
|
| 02/21/2019 |
4
| SETH SANDESH (Chairman & CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Exercised (in-or-at-the-money) 8,125 shares
@ $0.6, valued at
$4.9k
|
|
| 12/10/2018 |
4
| SETH SANDESH (Chairman & CEO) has filed a Form 4 on Actinium Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $0.4372, valued at
$4.4k
|
|
|
|
|